Broken String Biosciences

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation

Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will support development and commercialisation strategy for INDUCE-seq DNA break-mapping platform 2 October 2023 -- Cambridge, UK -- Broken String Biosciences, a genomics company building a...

Broken String Biosciences Closes $15m Series A Funding Round

Funds to support further development and commercialisation of the company’s INDUCE-seq DNA break mapping technology Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression of cell and gene therapy programmes New investors include Illumina Ventures, Mérieux Equity Partners and HERAN Partners 18 September 2023 -- Cambridge, UK -- Broken...
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

+44(0)1223 786 071